TP53 and breast carcinoma: To address the role of aggregated p53 and the prion-like effect in triggering cancer development and progression, we observed a greater extent of mutant p53 co-aggregation with amyloid oligomers in breast cancer MDA-MB-231 cells compared with wt p53 cells (MCF7) (22).